Listed by the USPTO as STEPHENS, AMELIA CAROLE
Tech Center 1600 • Art Units: 1638 1644 1645 1656 1675 1677
This examiner grants 75% of resolved cases
STEPHENS, AMELIA CAROLE works in Tech Center 1600 and Art Unit 1638. The profile contains 8 resolved cases, with an allowance rate of 75.0%. Interviews show a 50.0% lift, and the median time to allowance is 1044 days. Because the resolved-case base is limited, these figures provide a focused signal rather than a broad historical record.
The listed companies are The Regents of the University of California, Bristol-Myers Squibb Company, and Genentech Inc. The firms are Sheppard, Mullin, Richter & Hampton LLP, RENNER, OTTO, BOISSELLE & SKLAR, LLP, and Casimir Jones, S.C. Counsel can use the profile for initial planning, while treating the limited case history as an important qualification on interpretation.
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18688962 | Heterohexameric Fusion Constructs for Protein Expression in Cyanobacteria | Non-Final OA | The Regents of the University of California |
| 18290730 | DE-CLUSTERING INHIBITORS OF PTPRA | Non-Final OA | The Regents of the University of California |
| 18928711 | COMPOSITION FOR PREVENTING OR TREATING ALZHEIMER'S DISEASE COMPRISING PHOSPHOLIPASE C ACTIVATOR AS AN ACTIVE INGREDIENT | Non-Final OA | Korea University Research and Business Foundation |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy75.0% of resolved applications examined by Amelia Carole Stephens were allowed (8 resolved cases), compared with 48.8% across Art Unit 1638 over the last five years.
This examiner's interview lift is +50.0 percentage points: the difference in allowance rate between resolved applications that had an examiner interview and those that did not.
Applications allowed by Amelia Carole Stephens took 1,044 days on average from filing to allowance.
Amelia Carole Stephens examines applications in Art Unit 1638 in Tech Center 1600 (Biotechnology & Pharmaceuticals).
